Piper Sandler Upgrades Amphastar Pharmaceuticals to Overweight, Raises Price Target to $28
Piper Sandler analyst David Amsellem upgrades Amphastar Pharmaceuticals (NASDAQ:AMPH) from Neutral to Overweight and raises the price target from $21 to $28.
Amphastar Pharmaceuticals: Q3 Earnings Insights
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
Amphastar Pharmaceuticals Q2 Adj. EPS $0.21, Inline, Sales $101.70M Miss $101.78M Estimate
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last
Looking into Amphastar Pharmaceuticals’s Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q1, Amphastar Pharmaceuticals (NASDAQ:AMPH) earned $10.31 million, a 257.97% increase from the preceding quarter.
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)